Advanced Research Center, Inc. — research payments reported

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$19,633	1
2024	Research	$16,400	11
2023	Research	$868	10
2022	Research	$24,374	13
2021	Research	$9,440	3
2020	Research	$80,303	3

Breakdown

Who paid Research payments · program years 2020–2025

H. Lundbeck A S $80,303 3 payments
Alkermes, Inc. $61,275 35 payments
Sunovion Pharmaceuticals Inc. $9,440 3 payments

Studies the money was for Research payments · program years 2020–2025

Evaluate Efficacy & Safety of Eptinezumab Administered Intravenously in Subjects Experiencing Acute Attack of Migraine (RELIEF) $80,303 3 payments
A Phase 3, Randomized, Double-Blind, 52-Week Study of OLZ/SAM vs Olanzapine to Evaluate Weight Gain as Assessed by Change in BMI Z-Score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder (ENLIGHTEN-Youth) $28,742 26 payments
Long-term, safety extension study of OLZ/SAM in pediatric subjects with schizophrenia or bipolar I disorder $19,633 1 payment
Long-term, safety extension study of OLZ/SAM in pediatric subjects with schizophrenia or bipolar I disorder (ENLIGHTEN Youth Extension) $12,900 8 payments
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia $9,440 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.